Effect of bosentan therapy in persistent pulmonary hypertension of the newborn
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 59 (1) , 58-64
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Patient Characteristics in Persistent Pulmonary Hypertension of the NewbornPulmonary Medicine, 2011
- Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan useEuropean Journal of Pediatrics, 2011
- Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE‐1 studyBritish Journal of Clinical Pharmacology, 2009
- Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentanEuropean Journal of Pediatrics, 2007
- Blood pressure disorders in the neonate: Hypotension and hypertensionSeminars in Fetal and Neonatal Medicine, 2006
- Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded StudyPediatrics, 2006
- Neonatal Persistent Pulmonary Hypertension Treated with Milrinone: Four Case ReportsNeonatology, 2006
- Pulmonary hypertension in the newbornPaediatric Respiratory Reviews, 2005
- Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor AntagonistClinical Pharmacokinetics, 2004
- Plasma Immunoreactive Endothelin-1 Concentrations in Infants with Persistent Pulmonary Hypertension of the NewbornAmerican Journal of Perinatology, 1996